{"job_id": "f59d37cf-9e47-4498-8c57-c66f812a9306", "brochure_id": "f59d37cf-9e47-4498-8c57-c66f812a9306", "brochure_name": "Onco Audit Brochure  Annoated - 3rd Sept (1).pdf", "status": "completed", "results": [{"statement": "Khetan AK, Palileo-Villanueva LM, Mat-Nasir N, et al. Mortality, cardiovascular disease, and their associations with risk factors in Southeast Asia. JACC Asia. 2024;4(8):624-633. doi:10.1016/j.jaca-si.2024.05.008", "reference_no": "1", "reference": "Khetan AK, Palileo-Villanueva LM, Mat-Nasir N, et al. Mortality, cardiovascular disease, and their associations with risk factors in Southeast Asia. JACC Asia. 2024;4(8):624-633. doi:10.1016/j.jaca- si.2024.05.008", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 1.Khetan AK.pdf: JACC Asia. 2024 Jul 30;4(8):624-633. doi: 10.1016/j.jacasi.2024.05.008|Mortality, Cardiovascular Disease, and Their Associations With Risk Factors in Southeast Asia", "validation_result": "Supported", "page_location": "First page of the article", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Wilson BE, Jacob S, Yap ML, Ferlay J, Bray F, Barton MB. Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study. Lancet Oncol. 2019;20(6):769-780. doi:10.1016/S1470-2045(19)30163-9", "reference_no": "2", "reference": "Wilson BE, Jacob S, Yap ML, Ferlay J, Bray F, Barton MB. Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study. Lancet Oncol. 2019;20(6):769-780. doi:10.1016/S1470-2045(19)30163-9 3.Duggan C, Carr PJ, Gavin N, et al. Vascular access devices for prolonged intravenous therapy regimens in people diagnosed with cancer. Cochrane Database Syst Rev. 2024;2024(9):CD015667. doi:10.1002/14651858.CD015667 4.Garcia MA, Kalecinski J, Oriol M, et al. Cancer patients treated with intravenous chemotherapy for the first time: what are their needs? What do they lack? A qualitative\u2013quantitative mixed approach. Patient Prefer Adherence. 2018;12:1853-1861. doi:10.2147/PPA.S1698105. Bahl A, Johnson S, Alsbrooks K, Mares A, Gala S, Hoerauf K. Defining difficult intravenous access (DIVA): a systematic review. J Vasc Access. 2021;0(0):112972982110596. doi:10.1177/11297298211059648", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 2.Wilson BE,2019.pdf: Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study", "validation_result": "Supported", "page_location": "Title of the article", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Duggan C, Carr PJ, Gavin N, et al. Vascular access devices for prolonged intravenous therapy regimens in people diagnosed with cancer. Cochrane Database Syst Rev. 2024;2024(9):CD015667. doi:10.1002/14651858.CD015667", "reference_no": "3", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 3.Duggan C, 2024.pdf: Duggan C, Carr PJ, Gavin N, Walsh S, Simpkin A, Byrnes J, Ruhlmann CH, Chan RJ, Hernon O. Vascular access devices for prolonged intravenous therapy regimens in people diagnosed with cancer (Protocol).|Cochrane Database of Systematic Reviews 2024, Issue 8. Art. No.: CD015667.|DOI: 10.1002/14651858.CD015667.", "validation_result": "Supported", "page_location": "Title page, citation", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Garcia MA, Kalecinski), Oriol M, et al. Cancer patients treated with intravenous chemotherapy for the first time: what are their needs? What do they lack? A qualitative-quantitative mixed approach. Patient Prefer Adherence. 2018;12:1853-1861. doi:10.2147/PPA.S169810", "reference_no": "4", "reference": "", "matched_paper": "None", "matched_evidence": "No matching reference PDF was found for the extraction: 4", "validation_result": "Reference Missing", "page_location": "N/A", "confidence_score": 0.0, "matching_method": "Reference Filter", "analysis_summary": "Validation skipped: Reference Missing", "confidence_band": "LOW"}, {"statement": "Bahl A, Johnson S, Alsbrooks K, Mares A, Gala S, Hoerauf K. Defining difficult intravenous access (DIVA): a systematic review. ] Vasc Access. 2021;0(0):112972982110596. doi:10.1177/11297298211059648", "reference_no": "5", "reference": "", "matched_paper": "None", "matched_evidence": "No matching reference PDF was found for the extraction: 5", "validation_result": "Reference Missing", "page_location": "N/A", "confidence_score": 0.0, "matching_method": "Reference Filter", "analysis_summary": "Validation skipped: Reference Missing", "confidence_band": "LOW"}, {"statement": "Eren H. Difficult intravenous access and its management. In: Vascular Access Devices. IntechOpen; 2021. https://www.intechopen.com/chapters/754777", "reference_no": "6", "reference": "Eren H. Difficult intravenous access and its management. In: Vascular Access Devices. IntechOpen; 2021. https://www.intechopen.com/chapters/754777. BD-34_DiVA Quantitative Final Report - vFF. [Unpublished internal report].", "matched_paper": "None", "matched_evidence": "No matching reference PDF was found for the extraction: 6", "validation_result": "Reference Missing", "page_location": "N/A", "confidence_score": 0.0, "matching_method": "Reference Filter", "analysis_summary": "Validation skipped: Reference Missing", "confidence_band": "LOW"}, {"statement": "References. BD-34_DiVA Quantitative Final Report - vFF. [Unpublished internal report].", "reference_no": "7", "reference": "", "matched_paper": "None", "matched_evidence": "No matching reference PDF was found for the extraction: 7", "validation_result": "Reference Missing", "page_location": "N/A", "confidence_score": 0.0, "matching_method": "Reference Filter", "analysis_summary": "Validation skipped: Reference Missing", "confidence_band": "LOW"}, {"statement": "References. NSC_BD_Project Bolt_Quantitative Research Report_20211213. [Unpublished internal report].", "reference_no": "8", "reference": "NSC_BD_Project Bolt_Quantitative Research Report_20211213. [Unpublished internal report].", "matched_paper": "None", "matched_evidence": "No matching reference PDF was found for the extraction: 8", "validation_result": "Reference Missing", "page_location": "N/A", "confidence_score": 0.0, "matching_method": "Reference Filter", "analysis_summary": "Validation skipped: Reference Missing", "confidence_band": "LOW"}, {"statement": "Paterson RS, Schults JA, Slaughter E, et al. Review article: Peripheral intravenous catheter insertion in adult patients with difficult intravenous access: A systematic review of assessment instruments, clinical practice guidelines and escalation pathways. Emergency Medicine Australasia. 2022;34(6):862-870.", "reference_no": "9", "reference": "Paterson RS, Schults JA, Slaughter E, et al. Review article: Peripheral intravenous catheter insertion in adult patients with difficult intravenous access: A systematic review of assessment instruments, clinical practice guidelines and escalation pathways. Emergency Medicine Australasia. 2022;34(6):862-870.", "matched_paper": "None", "matched_evidence": "No matching reference PDF was found for the extraction: 9", "validation_result": "Reference Missing", "page_location": "N/A", "confidence_score": 0.0, "matching_method": "Reference Filter", "analysis_summary": "Validation skipped: Reference Missing", "confidence_band": "LOW"}, {"statement": "Witting MD. IV access difficulty: predictors and clinical outcomes.) Emerg Med. 2012;42(4):483-487.", "reference_no": "10", "reference": "Witting MD. IV access difficulty: predictors and clinical outcomes. J Emerg Med. 2012;42(4):483-487.11. Twibell KR, Hofstetter P, Siela D, Brown D, Jones HM. A comparative study of blood sampling from venipuncture and short peripheral catheters in pediatric inpatients. J Infus Nurs. 2019;42(5):239-245. doi:10.1097/NAN.0000000000000338", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 10.Witting2012.pdf: Intravenous access difficulty (IVAD) has long been recognized as a problem for emergency departments (ED), but epidemiologic data are lacking.|Objective: To estimate the incidence of IVAD and its associated delays in an urban ED.", "validation_result": "Supported", "page_location": "Abstract", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Twibell KR, Hofstetter P, Siela D, Brown D, Jones HM. A comparative study of blood sampling from venipuncture and short peripheral catheters in pediatric inpatients. J Infus Nurs. 2019;42(5):239-245. doi:10.1097/NAN.0000000000000338", "reference_no": "11", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 11. Twibell2019.pdf: This prospective, comparative study examined blood test results, hemolysis rates, and patient perceptions related to 2 blood sampling methods in pediatric inpatients (N = 95). | Blood specimens were drawn via venipuncture and a short peripheral catheter used for fluid administration.", "validation_result": "Supported", "page_location": "Abstract", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Rodriguez-Calero MA, de Pedro-Gomez JE, Molero-Ballester LJ, et al. Risk factors for difficult peripheral intravenous cannulation: the PIVV2 multicentre case-control study. J Clin Med. 2020;9(3):799. doi:10.3390/jcm9030799", "reference_no": "12", "reference": "Rodriguez-Calero MA, de Pedro-Gomez JE, Molero-Ballester LJ, et al. Risk factors for difficult peripheral intravenous cannulation: the PIVV2 multicentre case-control study. J Clin Med. 2020;9(3):799. doi:10.3390/jcm9030799 13.Sou V, McManus C, Mifflin N, Frost SA, Ale J, Alexandrou E. A clinical pathway for the management of difficult venous access. BMC Nurs. 2017;16(1):64. doi:10.1186/s12912-017-0261-z 14.Gallieni M, Pittiruti M, Biffi R. Vascular access in oncology patients. CA Cancer J Clin. 2008;58(6):323-346. doi:10.3322/ca.2008.0015", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 12.Rodriguez,2020.pdf: J Clin Med. 2020 Mar 15;9(3):799. doi: 10.3390/jcm9030799|Risk Factors for Difficult Peripheral Intravenous Cannulation. The PIVV2 Multicentre Case-Control Study", "validation_result": "Supported", "page_location": "First page of article", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Sou V, McManus C, Mifflin N, Frost SA, Ale J, Alexandrou E. A clinical pathway for the management of difficult venous access. BMC Nurs. 2017;16(1):64. doi:10.1186/s12912-017-0261-z", "reference_no": "13", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 13.Sou2017.pdf: Sou V, McManus C, Mifflin N, Frost SA, Ale J, Alexandrou E. A clinical pathway for the management of difficult venous access. BMC Nurs. 2017;16(1):64.", "validation_result": "Supported", "page_location": "Paper title", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Gallieni M, Pittiruti M, Biffi R. Vascular access in oncology patients. CA Cancer J Clin. 2008;58(6):323-346. doi:10.3322/ca.2008.0015", "reference_no": "14", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 14.Gallieni M,2008.pdf: Maurizio Gallieni, MD; Mauro Pittiruti, MD; Roberto Biffi, MD", "validation_result": "Supported", "page_location": "First page, author information", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "LeVasseur N, Stober C, Daigle K, et al. Optimizing vascular access for patients receiving intravenous systemic therapy for early-stage breast cancer: a survey of oncology nurses and physicians. Curr Oncol. 2018;25(4):e298-e304.", "reference_no": "15", "reference": "LeVasseur N, Stober C, Daigle K, et al. Optimizing vascular access for patients receiving intravenous systemic therapy for early-stage breast cancer: a survey of oncology nurses and physicians. Curr Oncol. 2018;25(4):e298-e304.16.Nyman HA, Jorgenson JA, Slawson MH. Workplace contamination with antineoplastic agents in a new cancer hospital using a closed-system drug transfer device. Hosp Pharm. 2007;42(3):219-225.17.Wick C, Slawson MH, Jorgenson JA, Tyler LS. Using a closed-system protective device to reduce personnel exposure to antineoplastic agents. Am J Health Syst Pharm. 2003;60(22):2314-2320. 18.International Society of Oncology Pharmacy Practitioners. ISOPP Standards for the Safe Handling of Cytotoxics. J Oncol Pharm Pract. 2022;28(3_sup- pl):S1-S126.19.Abu-Alhaija D, Bakas T, Shaughnessy E, Miller E. The factors that influence chemotherapy exposure among nurses: an integrative review. Workplace Health Saf. 2023;71(4):149-160. doi:10.1177/21650799221140583. 20.Cavallo D, Ursini CL, Perniconi B, et al. Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees. Mutat Res. 2005;587(1-2):45-51. 21.McDiarmid MA, Oliver MS, Roth TS, Rogers B, Escalante C. Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. J Occup Environ Med. 2010;52(10):1028-1034. doi:10.1097/JOM.0b013e3181f73ae6", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 15. LeVasseur N,2018.pdf: Curr Oncol. 2018 Aug 14;25(4):e298\u2013e304. doi: 10.3747/co.25.3903|Optimizing vascular access for patients receiving intravenous systemic therapy for early-stage breast cancer-a survey of oncology nurses and physicians|N LeVasseur, C Stober', K Daigle A Robinson \u00a7, S McDiarmid *, S Mazzarello\u00b9, B Hutton", "validation_result": "Supported", "page_location": "Title page", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Nyman HA, Jorgenson JA, Slawson MH. Workplace contamination with antineoplastic agents in a new cancer hospital using a closed-system drug transfer device. Hosp Pharm. 2007;42(3):219-225.", "reference_no": "16", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 16.Nyman,2007.pdf: Workplace Contamination with Antineoplastic Agents in a New Cancer Hospital Using a Closed-System Drug Transfer Device", "validation_result": "Supported", "page_location": "Title of the article", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Wick C, Slawson MH, Jorgenson JA, Tyler LS. Using a closed-system protective device to reduce personnel exposure to antineoplastic agents. Am J Health Syst Pharm. 2003;60(22):2314-2320.", "reference_no": "17", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 17.Wick,2003.pdf: Abstract: Surface contamination with and personnel exposure to antineoplastic agents before and after the implementation of a closed-system protective device were studied.", "validation_result": "Supported", "page_location": "Abstract section", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "International Society of Oncology Pharmacy Practitioners. ISOPP Standards for the Safe Handling of Cytotoxics. Oncol Pharm Pract. 2022;28(3_suppl):S1-S126.", "reference_no": "18", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 18. ISOPP.pdf: Volume 28 Number 3 (Supplement) April 2022|ISOPP Standards for the Safe Handling of Cytotoxics", "validation_result": "Supported", "page_location": "Title page", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Abu-Alhaija D, Bakas T, Shaughnessy E, Miller E. The factors that influence chemotherapy exposure among nurses: an integrative review. Workplace Health Saf. 2023;71(4):149-160. doi:10.1177/21650799221140583.", "reference_no": "19", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 19.Abu-Alhaija D,2023.pdf: Abstract: Background: Exposure to chemotherapy is\nan occupational hazard predisposing nurses to severe\nhealth effects. | The purpose of this integrative review\nwas to identify the recent literature describing the risk\nfactors for occupational exposure to chemotherapy\namong nurses.", "validation_result": "Supported", "page_location": "Abstract section", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Cavallo D, Ursini CL, Perniconi B, et al. Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees. Mutat Res. 2005;587(1-2):45-51.", "reference_no": "20", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 20.Cavallo,2005.pdf: The aim of this study was to evaluate genotoxic effects of antineoplastic drugs in nurses (n = 25) and pharmacy technicians (n = 5) employed in an oncology hospital.|We performed the micronucleus (MN) test with lymphocytes and exfoliated buccal cells and conducted traditional analysis of chromosomal aberrations (CA).", "validation_result": "Supported", "page_location": "Abstract", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "McDiarmid MA, Oliver MS, Roth TS, Rogers B, Escalante C. Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. ) Occup Environ Med. 2010;52(10):1028-1034. doi:10.1097/]OM.0b013e3181f73ae6", "reference_no": "21", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 21. Mcdiarmid,2010.pdf: Objective: To determine the frequency of \"signature\" chromosomal abnormalities in oncology workers handling anticancer drugs. | Methods: Peripheral blood from health care personnel (N = 109) was examined with probes for targets on chromosomes 5, 7, and 11.", "validation_result": "Supported", "page_location": "Page 1, Abstract", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Skov T, Maarup B, Olsen J, R\u00f8rth M, Winthereik H, Lynge E. Leukaemia and reproductive outcome among nurses handling antineoplastic drugs. Br J Ind Med. 1992;49(12):855-861.", "reference_no": "22", "reference": "Skov T, Maarup B, Olsen J, R\u00f8rth M, Winthereik H, Lynge E. Leukaemia and reproductive outcome among nurses handling antineoplastic drugs. Br J Ind Med. 1992;49(12):855-861.", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 22.Skov T, 1992.pdf: Leukaemia and reproductive outcome among nurses handling antineoplastic drugs.", "validation_result": "Supported", "page_location": "Title of the article", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Hansen J, Olsen JH. Cancer morbidity among Danish female pharmacy technicians. Scand J Work Environ Health. 1994;20(1):22-26.", "reference_no": "23", "reference": "Hansen J, Olsen JH. Cancer morbidity among Danish female pharmacy technicians. Scand J Work Environ Health. 1994;20(1):22-26.", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 23.Hansen J,1994.pdf: HANSEN J, OLSEN JH. Cancer morbidity among Danish female pharmacy technicians. Scand J Work\nEnviron Health 1994;20:22-6.", "validation_result": "Supported", "page_location": "Page 2, Abstract", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Sotaniemi EA, Sutinen S, Arranto AJ, et al. Liver damage in nurses handling cytostatic agents. Acta Med Scand. 1983;214(3):181-189.", "reference_no": "24", "reference": "Sotaniemi EA, Sutinen S, Arranto AJ, et al. Liver damage in nurses handling cytostatic agents. Acta Med Scand. 1983;214(3):181-189. 25.Lawson CC, Rocheleau CM, Whelan EA, et al. Occupational exposures among nurses and risk of spontaneous abortion. Am J Obstet Gynecol. 2012;206(4):327.e1-327.e8. 26.Hemminki K, Kyronen P, Lindbohm ML. Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals. J Epidemiol Community Health. 1985;39(2):141-147. 27.Hon CY, Teschke K, Chu W, Demers P, Venners S. Antineoplastic drug contamination of surfaces throughout the hospital medication system in Canadian hospitals. J Occup Environ Hyg. 2013;10(7):374-383. doi:10.1080/15459624.2013.789743", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 24.Sotaniemi EA,1983.pdf: Three consecutive head nurses developed liver injury after years of handling cytostatic drugs.", "validation_result": "Supported", "page_location": "Abstract", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Lawson CC, Rocheleau CM, Whelan EA, et al. Occupational exposures among nurses and risk of spontaneous abortion. Am J Obstet Gynecol. 2012;206(4):327.e1-327.e8.", "reference_no": "25", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 25.Lawson CC, 2012.pdf: Am J Obstet Gynecol. Author manuscript; available in PMC: 2015 Sep 17.|Published in final edited form as: Am J Obstet Gynecol. 2011 Dec 30;206(4):327.e1\u2013327.e8. doi: 10.1016/j.ajog.2011.12.030", "validation_result": "Supported", "page_location": "Page 1, citation information", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Hemminki K, Kyronen P, Lindbohm ML. Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals.) Epidemiol Community Health. 1985;39(2):141-147.", "reference_no": "26", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 26.Hemminki K, 1985.pdf: Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals, based on registered information of outcome.", "validation_result": "Supported", "page_location": "Title of the paper", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Hon CY, Teschke K, Chu W, Demers P, Venners S. Antineoplastic drug contamination of surfaces throughout the hospital medication system in Canadian hospitals. ) Occup Environ Hyg. 2013;10(7):374-383. doi:10.1080/15459624.2013.789743", "reference_no": "27", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 27.Hon CY,2013.pdf: Antineoplastic Drug Contamination of Surfaces Throughout the Hospital Medication System in Canadian Hospitals", "validation_result": "Supported", "page_location": "Title of the article", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Hon CY. Side-by-side comparison of methods for environmental monitoring for hazardous drug contamination. Can] Hosp Pharm. 2023;76(2):87-93. doi:10.4212/cjhp.3275", "reference_no": "28", "reference": "Hon CY. Side-by-side comparison of methods for environmental monitoring for hazardous drug contamination. Can J Hosp Pharm. 2023;76(2):87-93. doi:10.4212/cjhp.3275", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 28.Hon CY,2023.pdf: Side-by-Side Comparison of Methods for Environmental Monitoring for Hazardous Drug Contamination", "validation_result": "Supported", "page_location": "Title of the article", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Kiffmeyer TK, Tuerk J, Hahn M, et al. Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies-the MEWIP project. Ann \u041e\u0441\u0441\u0438\u0440 \u041d\u0443\u0434. 2013;57(4):444-455. doi:10.1093/annhyg/mes081.", "reference_no": "29", "reference": "Kiffmeyer TK, Tuerk J, Hahn M, et al. Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies\u2013the MEWIP project. Ann Occup Hyg. 2013;57(4):444-455. doi:10.1093/annhyg/mes081.", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 29.Kiffmeyer TK, 2013.pdf: Application and Assessment of a Regular Environmental Monitoring of the Antineoplastic Drug Contamination Level in Pharmacies - The MEWIP Project", "validation_result": "Supported", "page_location": "Title of the paper", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Boiano JM, Steege AL, Sweeney MH. Adherence to safe handling guidelines by health care workers who administer antineoplastic drugs.] Occup Environ Hyg. 2014;11(11):728-740.", "reference_no": "30", "reference": "Boiano JM, Steege AL, Sweeney MH. Adherence to safe handling guidelines by health care workers who administer antineoplastic drugs. J Occup Environ Hyg. 2014;11(11):728-740. 31.United States Pharmaco- peial Convention. USP General Chapter <800> Hazardous Drugs\u2014Handling in Healthcare Settings. Published February 1, 2016. Updated 2022. Accessed August 5, 2025. https://www.usp.org/compounding/gener- al-chapter-hazardous-drugs-handling-healthcare", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 30 .Boiano JM,2015.pdf: The primary purpose of this study is to describe chemotherapy drug administration practices and extent of use of exposure controls, and impediments to PPE use by health care workers who administer antineoplastic drugs.", "validation_result": "Supported", "page_location": "Page 3, Introduction", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "United States Pharmacopeial Convention. USP General Chapter <800> Hazardous Drugs-Handling in Healthcare Settings. Published February 1, 2016. Updated 2022. Accessed August 5, 2025. https://www.usp.org/compounding/general-chapter-hazardous-drugs-handling-healthcare", "reference_no": "31", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 31.USP chapter 800.pdf: General chapter <800> was published in USP-NF on February 1, 2016 and will become official on December 1, 2019.", "validation_result": "Supported", "page_location": "Page 1, paragraph 3", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Why Optimizing IV Chemotherapy Matters. Cancer ranks among the top 3 causes of death in Asia.", "reference_no": "1", "reference": "Khetan AK, Palileo-Villanueva LM, Mat-Nasir N, et al. Mortality, cardiovascular disease, and their associations with risk factors in Southeast Asia. JACC Asia. 2024;4(8):624-633. doi:10.1016/j.jaca- si.2024.05.008", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 1.Khetan AK.pdf: A total of 2,226 (11%) members of the cohort died during a follow-up period of a mean of 8.2 \u00b1\n4.0 years. | The mortality rate was 13.7 (95% CI: 13.1-14.2) per 1,000 person-years. | The most\ncommon cause of mortality was CVD (38% of mortality), followed by cancer (12%), respiratory\ndiseases (10.5%), infection (8.7%), and injury (4.4%) (Figure 1).", "validation_result": "Supported", "page_location": "Page 10, Mortality section", "confidence_score": 0.94, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Why Optimizing IV Chemotherapy Matters. Up to 60% of cancer patients receive chemotherapy as a part of their treatment.", "reference_no": "2", "reference": "Wilson BE, Jacob S, Yap ML, Ferlay J, Bray F, Barton MB. Estimates of global chemotherapy demands and corresponding physician workforce requirements for 2018 and 2040: a population-based study. Lancet Oncol. 2019;20(6):769-780. doi:10.1016/S1470-2045(19)30163-9 3.Duggan C, Carr PJ, Gavin N, et al. Vascular access devices for prolonged intravenous therapy regimens in people diagnosed with cancer. Cochrane Database Syst Rev. 2024;2024(9):CD015667. doi:10.1002/14651858.CD015667 4.Garcia MA, Kalecinski J, Oriol M, et al. Cancer patients treated with intravenous chemotherapy for the first time: what are their needs? What do they lack? A qualitative\u2013quantitative mixed approach. Patient Prefer Adherence. 2018;12:1853-1861. doi:10.2147/PPA.S1698105. Bahl A, Johnson S, Alsbrooks K, Mares A, Gala S, Hoerauf K. Defining difficult intravenous access (DIVA): a systematic review. J Vasc Access. 2021;0(0):112972982110596. doi:10.1177/11297298211059648", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 2.Wilson BE,2019.pdf: According to GLOBOCAN estimates,\u00b9 there were approximately 17.0 million new cancer cases and 9.5 million deaths from cancer worldwide (excluding non-melanomatous skin cancers) in 2018.", "validation_result": "Supported", "page_location": "Page 1, Introduction section", "confidence_score": 0.94, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Why Optimizing IV Chemotherapy Matters. Intravenous (IV) chemotherapy is a key treatment modality in oncology care, offering rapid drug delivery and a systemic response, making it crucial for cancer patients.", "reference_no": "3", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 3.Duggan C, 2024.pdf: Systemic anti-cancer therapy (SACT) has evolved over the past 20 years.|The majority of SACT is delivered intravenously.|Therefore, the insertion of a vascular access device (VAD) is a prerequisite (Kim 2021).", "validation_result": "Supported", "page_location": "Page 4, Background section", "confidence_score": 0.94, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Patient-Centric Challenges in IV Chemotherapy. Difficult Intravenous Access (DIVA) - Difficult Intravenous Access (DIVA) refers to the challenge of securing IV access due to two or more failed attempts using traditional techniques, absence of visible or palpable veins, or a known history of DIVA.", "reference_no": "5", "reference": "", "matched_paper": "None", "matched_evidence": "No matching reference PDF was found for the extraction: 5", "validation_result": "Reference Missing", "page_location": "N/A", "confidence_score": 0.0, "matching_method": "Reference Filter", "analysis_summary": "Validation skipped: Reference Missing", "confidence_band": "LOW"}, {"statement": "Patient-Centric Challenges in IV Chemotherapy. One of the major contributing factors to DIVA is the frequent cannulation attempts for IV chemotherapy administration, which often results in venous depletion, compromising vein integrity and making future cannulation more difficult.", "reference_no": "6", "reference": "Eren H. Difficult intravenous access and its management. In: Vascular Access Devices. IntechOpen; 2021. https://www.intechopen.com/chapters/754777. BD-34_DiVA Quantitative Final Report - vFF. [Unpublished internal report].", "matched_paper": "None", "matched_evidence": "No matching reference PDF was found for the extraction: 6", "validation_result": "Reference Missing", "page_location": "N/A", "confidence_score": 0.0, "matching_method": "Reference Filter", "analysis_summary": "Validation skipped: Reference Missing", "confidence_band": "LOW"}, {"statement": "Patient-Centric Challenges in IV Chemotherapy. 7x increase in costs due to catheter replacements", "reference_no": "5,9", "reference": "", "matched_paper": "None", "matched_evidence": "No matching reference PDF was found for the extraction: 5,9", "validation_result": "Reference Missing", "page_location": "N/A", "confidence_score": 0.0, "matching_method": "Reference Filter", "analysis_summary": "Validation skipped: Reference Missing", "confidence_band": "LOW"}, {"statement": "Patient-Centric Challenges in IV Chemotherapy. Delays in treatment", "reference_no": "10", "reference": "Witting MD. IV access difficulty: predictors and clinical outcomes. J Emerg Med. 2012;42(4):483-487.11. Twibell KR, Hofstetter P, Siela D, Brown D, Jones HM. A comparative study of blood sampling from venipuncture and short peripheral catheters in pediatric inpatients. J Infus Nurs. 2019;42(5):239-245. doi:10.1097/NAN.0000000000000338", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 10.Witting2012.pdf: Conclusion: Severe IVAD, requiring advanced techniques or physician assistance, occurred in 5% of cases and was associated with marked delays.|Abstract-Conclusion: In an urban, tertiary care ED, mild and moderate IVAD was common and led to mild delays, but severe IVAD, requiring a physician, caused substantial delays.", "validation_result": "Supported", "page_location": "Abstract, Conclusion", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Patient-Centric Challenges in IV Chemotherapy. High risk of catheter-related complications (phlebitis, infection, and sepsis)", "reference_no": "12", "reference": "Rodriguez-Calero MA, de Pedro-Gomez JE, Molero-Ballester LJ, et al. Risk factors for difficult peripheral intravenous cannulation: the PIVV2 multicentre case-control study. J Clin Med. 2020;9(3):799. doi:10.3390/jcm9030799 13.Sou V, McManus C, Mifflin N, Frost SA, Ale J, Alexandrou E. A clinical pathway for the management of difficult venous access. BMC Nurs. 2017;16(1):64. doi:10.1186/s12912-017-0261-z 14.Gallieni M, Pittiruti M, Biffi R. Vascular access in oncology patients. CA Cancer J Clin. 2008;58(6):323-346. doi:10.3322/ca.2008.0015", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 12.Rodriguez,2020.pdf: DPIVC has been reported to affect 10%-24% of hospitalized adults and is associated with higher rates of catheter failure, provoking more frequent catheter replacement [8].|This may produce serious complications associated with vascular access, such as phlebitis, extravasation, bruising, haemorrhages, catheter-associated infection and sepsis, thus aggravating morbidity [9,10].", "validation_result": "Supported", "page_location": "Page 2, Introduction", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Patient-Centric Challenges in IV Chemotherapy. Overall dissatisfaction with care", "reference_no": "11", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 11. Twibell2019.pdf: Patients/parents rated distress and dissatisfaction with venipuncture as significantly greater compared with short peripheral catheter blood sampling (P < .001).", "validation_result": "Supported", "page_location": "Abstract", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Patient-Centric Challenges in IV Chemotherapy. Increased pain impacts patient experience", "reference_no": "13", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 13.Sou2017.pdf: Patients with DiVA may undergo multiple, painful at-tempts to gain peripheral venous access [7]. | This can have deleterious effects on patient care that include missed medication doses, signifi-cant pain and increased anxiety as well as increased risk of premature device failure [17, 20, 21]. | Patients reported a much higher level of pain with can-nulation attempts prior to referral for ultrasound guid-ance, some experienced severe pain with nearly a quarter (23.3%) of patients reporting a pain score of 10/10. | This significant finding illustrates the impact of needle pain which can cause anxiety, phobia and significantly reduce patient satisfaction with the health care facility [21].", "validation_result": "Supported", "page_location": "Page 1, Page 5, Page 6", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Patient-Centric Challenges in IV Chemotherapy. Vascular Access Complications with Peripheral Intravenous Catheter (PIVC) - 25% of cancer patients with vascular access devices experience complications.", "reference_no": "14", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 14.Gallieni M,2008.pdf: Data from a study commissioned by the Food and Drug Administration in the 1990s\u00b2 showed that the use of VADs\nis associated with a high complication rate (10% to 25% of all patients with VADs) and a morbidity of at least 10%;", "validation_result": "Supported", "page_location": "Page 1, Introduction section", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Patient-Centric Challenges in IV Chemotherapy. Based on a healthcare professionals' survey on the perceived incidence of complications due to PIVCs in oncology patients, it was found that:", "reference_no": "15", "reference": "LeVasseur N, Stober C, Daigle K, et al. Optimizing vascular access for patients receiving intravenous systemic therapy for early-stage breast cancer: a survey of oncology nurses and physicians. Curr Oncol. 2018;25(4):e298-e304.16.Nyman HA, Jorgenson JA, Slawson MH. Workplace contamination with antineoplastic agents in a new cancer hospital using a closed-system drug transfer device. Hosp Pharm. 2007;42(3):219-225.17.Wick C, Slawson MH, Jorgenson JA, Tyler LS. Using a closed-system protective device to reduce personnel exposure to antineoplastic agents. Am J Health Syst Pharm. 2003;60(22):2314-2320. 18.International Society of Oncology Pharmacy Practitioners. ISOPP Standards for the Safe Handling of Cytotoxics. J Oncol Pharm Pract. 2022;28(3_sup- pl):S1-S126.19.Abu-Alhaija D, Bakas T, Shaughnessy E, Miller E. The factors that influence chemotherapy exposure among nurses: an integrative review. Workplace Health Saf. 2023;71(4):149-160. doi:10.1177/21650799221140583. 20.Cavallo D, Ursini CL, Perniconi B, et al. Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees. Mutat Res. 2005;587(1-2):45-51. 21.McDiarmid MA, Oliver MS, Roth TS, Rogers B, Escalante C. Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. J Occup Environ Med. 2010;52(10):1028-1034. doi:10.1097/JOM.0b013e3181f73ae6", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 15. LeVasseur N,2018.pdf: Using a survey of Canadian oncologists and oncology nurses responsible for the care of breast cancer patients, we evaluated current access practices, perceptions of complications, and perceptions of risk, and we estimated complication rates and evaluated perceived risk factors for lymphedema.", "validation_result": "Supported", "page_location": "Page 1, Methods section", "confidence_score": 0.94, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Patient-Centric Challenges in IV Chemotherapy. Up to 17% Risk of extravasation", "reference_no": "15", "reference": "LeVasseur N, Stober C, Daigle K, et al. Optimizing vascular access for patients receiving intravenous systemic therapy for early-stage breast cancer: a survey of oncology nurses and physicians. Curr Oncol. 2018;25(4):e298-e304.16.Nyman HA, Jorgenson JA, Slawson MH. Workplace contamination with antineoplastic agents in a new cancer hospital using a closed-system drug transfer device. Hosp Pharm. 2007;42(3):219-225.17.Wick C, Slawson MH, Jorgenson JA, Tyler LS. Using a closed-system protective device to reduce personnel exposure to antineoplastic agents. Am J Health Syst Pharm. 2003;60(22):2314-2320. 18.International Society of Oncology Pharmacy Practitioners. ISOPP Standards for the Safe Handling of Cytotoxics. J Oncol Pharm Pract. 2022;28(3_sup- pl):S1-S126.19.Abu-Alhaija D, Bakas T, Shaughnessy E, Miller E. The factors that influence chemotherapy exposure among nurses: an integrative review. Workplace Health Saf. 2023;71(4):149-160. doi:10.1177/21650799221140583. 20.Cavallo D, Ursini CL, Perniconi B, et al. Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees. Mutat Res. 2005;587(1-2):45-51. 21.McDiarmid MA, Oliver MS, Roth TS, Rogers B, Escalante C. Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. J Occup Environ Med. 2010;52(10):1028-1034. doi:10.1097/JOM.0b013e3181f73ae6", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 15. LeVasseur N,2018.pdf: Medical oncologists and oncology nurses were both asked about the perceived incidence of complications with the various types of venous access (Table II).|Of the listed complications, sclerosis of the veins (31%) and risk of extravasation (7%-17%) were reported for peripheral IVs; no rates were reported for PICCs and ports.", "validation_result": "Supported", "page_location": "Page 12, under the section \"What Is the Perceived Incidence of Complications?\"", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Patient-Centric Challenges in IV Chemotherapy. 31% Sclerosis of the veins for future use", "reference_no": "15", "reference": "LeVasseur N, Stober C, Daigle K, et al. Optimizing vascular access for patients receiving intravenous systemic therapy for early-stage breast cancer: a survey of oncology nurses and physicians. Curr Oncol. 2018;25(4):e298-e304.16.Nyman HA, Jorgenson JA, Slawson MH. Workplace contamination with antineoplastic agents in a new cancer hospital using a closed-system drug transfer device. Hosp Pharm. 2007;42(3):219-225.17.Wick C, Slawson MH, Jorgenson JA, Tyler LS. Using a closed-system protective device to reduce personnel exposure to antineoplastic agents. Am J Health Syst Pharm. 2003;60(22):2314-2320. 18.International Society of Oncology Pharmacy Practitioners. ISOPP Standards for the Safe Handling of Cytotoxics. J Oncol Pharm Pract. 2022;28(3_sup- pl):S1-S126.19.Abu-Alhaija D, Bakas T, Shaughnessy E, Miller E. The factors that influence chemotherapy exposure among nurses: an integrative review. Workplace Health Saf. 2023;71(4):149-160. doi:10.1177/21650799221140583. 20.Cavallo D, Ursini CL, Perniconi B, et al. Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees. Mutat Res. 2005;587(1-2):45-51. 21.McDiarmid MA, Oliver MS, Roth TS, Rogers B, Escalante C. Chromosome 5 and 7 abnormalities in oncology personnel handling anticancer drugs. J Occup Environ Med. 2010;52(10):1028-1034. doi:10.1097/JOM.0b013e3181f73ae6", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 15. LeVasseur N,2018.pdf: Of the listed complications, sclerosis of the veins (31%) and risk of extravasation (7%-17%) were reported for peripheral IVs; no rates were reported for PICCs and ports.", "validation_result": "Supported", "page_location": "Page 12, under the section 'What Is the Perceived Incidence of Complications?'", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Occupational Hazards to HCPs in IV Chemotherapy. Exposure may occur at any point in the journey of a hazardous drug.", "reference_no": "16,17", "reference": "", "matched_paper": "Multiple PDFs (2/2 support)", "matched_evidence": "- 16.Nyman,2007.pdf: Health care workers who prepare and administer antineoplastic agents risk exposure to these drugs.\n- 17.Wick,2003.pdf: Abstract: Surface contamination with and personnel exposure to antineoplastic agents before and after the implementation of a closed-system protective device were studied.", "validation_result": "Supported", "page_location": "Page 1, Introduction | Page 1, Abstract", "confidence_score": 0.97, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 2 sources", "confidence_band": "HIGH"}, {"statement": "Hazardous Drug (HD) Contamination Check. A study of six hospitals found that frequently contacted surfaces at every stage of the hospital medication system had measurable levels of antineoplastic drug contamination.", "reference_no": "27", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 27.Hon CY,2013.pdf: Our study found that frequently contacted surfaces at every stage of the hospital medication system had measureable levels of antineoplastic drug contamination.", "validation_result": "Supported", "page_location": "Abstract, page 2", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Occupational Hazards to HCPs in IV Chemotherapy. Despite advances in oncology care, vascular access and administration of hazardous drugs continue to pose challenges for healthcare professionals, including oncology nurses, vascular access specialists, pharmacists, oncologists, quality and safety officers involved in VAD and IV chemotherapy care.", "reference_no": "18,19", "reference": "", "matched_paper": "Multiple PDFs (2/2 support)", "matched_evidence": "- 18. ISOPP.pdf: Since the initial release of the International Society of\nOncology Pharmacy Practitioners (ISOPP) Standards for\nthe Safe Handling of Cytotoxic Drugs in 2007, much has\nevolved in oncology pharmacy. |Safe handling practices\nhave been refined and new hazardous agents have been dis-\ncovered and developed for treatment to pose new chal-\nlenges for workers caring for their patients.\n- 19.Abu-Alhaija D,2023.pdf: Exposure to chemotherapy is an occupational hazard predisposing nurses to severe health effects.|The serious health effects of exposure to chemotherapy on nurses and other healthcare professionals are well documented and include genotoxicity (Bouraoui et al., 2011), frequent miscarriages, infertility, congenital abnormalities (Connor et al., 2014), and the increased the risk to develop cancer (NIOSH, 2016).", "validation_result": "Supported", "page_location": "Page 2, Introduction | Page 1, Background section | Page 2, Background section", "confidence_score": 0.94, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 2 sources", "confidence_band": "HIGH"}, {"statement": "Occupational Hazards to HCPs in IV Chemotherapy. The risks of handling hazardous drugs are real and significant:", "reference_no": "18", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 18. ISOPP.pdf: Occupational exposure to hazardous drugs and the potential\nhealth risk to healthcare workers first became a recognised\nsafety concern in the 1970s.|Working with hazardous drugs in health care settings may\ncause skin rashes, has been associated with infertility, mis-\ncarriage and birth defects, and raises concerns about the\npossible development of leukemia or other cancers.", "validation_result": "Supported", "page_location": "Page 4, Section 1.3 and Page 5, Section 1.7", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Occupational Hazards to HCPs in IV Chemotherapy. Detrimental effect on DNA - Staff handling HD show up to a 5x increase in certain chromosomal aberrations.", "reference_no": "20,21", "reference": "", "matched_paper": "Multiple PDFs (2/2 support)", "matched_evidence": "- 20.Cavallo,2005.pdf: Our CA analysis showed in exposed groups a significant increase (about 2.5-fold) of structural chromosomal aberrations, with a particular relevance for breaks (up to 5.0-fold) confirming the study of Burgaz et al. [23] who also found an increase of the CA frequency in a group of 26 nurses handling antineoplastic drugs.\n- 21. Mcdiarmid,2010.pdf: The highly exposed group, however, when compared with the nonexposed has a general trend of higher abnormality frequencies for almost every outcome examined, reaching statistical significance with excesses in structural abnormalities of chromosome 5 (0.02 vs 0.18; P = 0.04 for the nonexposed vs the highly exposed, respectively) and total changes in chromosome 5 (0.04 vs 0.29; P = 0.01).|Table 6 was constructed in a similar fashion as was Table 5 but using only alkylating agent handling events as the exposure measure.|At 100 handling events (corresponding to the top nine exposed participants), the IRRs observed for each type of abnormality for chromosomes 5 or 7 or both are 2- to 3-fold higher than those shown in Table 5 derived from the effect of any drug-handling event.", "validation_result": "Supported", "page_location": "Page 5, Discussion section | Page 3, Results section | Page 5, Results section", "confidence_score": 0.97, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 2 sources", "confidence_band": "HIGH"}, {"statement": "Occupational Hazards to HCPs in IV Chemotherapy. Increased risk of cancer development - Increased relative risk of leukemia for oncology nurses, 2.8x increase in non-melanoma cancer, and 3.7x increase in non-Hodgkin's lymphoma in pharmacy techs.", "reference_no": "22, 23", "reference": "", "matched_paper": "Multiple PDFs (2/2 support)", "matched_evidence": "- 22.Skov T, 1992.pdf: The relative risk (RR) for leukaemia was significantly increased (10.65) but based on only two cases, one of acute myeloblastic and one of chronic myeloid leukaemia.|We have carried out a study of leukaemia and non-Hodgkin's lymphoma among physicians who have worked with ADs.\" The RR for leukaemia was 2-85 (95% CI 0-51-16-02).\n- 23.Hansen J,1994.pdf: An increased risk for non-Hodgkin's lymphoma appeared among long-term pharmacy dispensers (N = 5, SIR 3.7, 95% CI 1.2-8.9).", "validation_result": "Supported", "page_location": "Page 1, Abstract | Page 3, Paragraph 6 | Page 2, Results section", "confidence_score": 0.92, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 2 sources", "confidence_band": "HIGH"}, {"statement": "Occupational Hazards to HCPs in IV Chemotherapy. Damage to internal organs - Three consecutive nurses handling cytostatic agents had liver damage.", "reference_no": "24", "reference": "Sotaniemi EA, Sutinen S, Arranto AJ, et al. Liver damage in nurses handling cytostatic agents. Acta Med Scand. 1983;214(3):181-189. 25.Lawson CC, Rocheleau CM, Whelan EA, et al. Occupational exposures among nurses and risk of spontaneous abortion. Am J Obstet Gynecol. 2012;206(4):327.e1-327.e8. 26.Hemminki K, Kyronen P, Lindbohm ML. Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthetic gases, cytostatic drugs, and other potential hazards in hospitals. J Epidemiol Community Health. 1985;39(2):141-147. 27.Hon CY, Teschke K, Chu W, Demers P, Venners S. Antineoplastic drug contamination of surfaces throughout the hospital medication system in Canadian hospitals. J Occup Environ Hyg. 2013;10(7):374-383. doi:10.1080/15459624.2013.789743", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 24.Sotaniemi EA,1983.pdf: Three consecutive head nurses developed liver injury after years of handling cytostatic drugs.", "validation_result": "Supported", "page_location": "Abstract", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Occupational Hazards to HCPs in IV Chemotherapy. Reproductive issues - 2x greater risk of miscarriage among staff handling antineoplastic drugs.", "reference_no": "25,26", "reference": "", "matched_paper": "Multiple PDFs (1/2 support)", "matched_evidence": "- 25.Lawson CC, 2012.pdf: After adjusting for age, parity, shift work, and hours worked, antineoplastic drug exposure was associated with a 2-fold increased risk of spontaneous abortion, particularly with early spontaneous abortion before the 12th week, and 3.5-fold increased risk among nulliparous women.", "validation_result": "Supported", "page_location": "Page 2, Results section", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 2 sources", "confidence_band": "HIGH"}, {"statement": "Hazardous Drug (HD) Contamination Check. A NIOSH survey of 1,954 healthcare professionals revealed that they touched other work surfaces while wearing chemotherapy gloves:", "reference_no": "30", "reference": "Boiano JM, Steege AL, Sweeney MH. Adherence to safe handling guidelines by health care workers who administer antineoplastic drugs. J Occup Environ Hyg. 2014;11(11):728-740. 31.United States Pharmaco- peial Convention. USP General Chapter <800> Hazardous Drugs\u2014Handling in Healthcare Settings. Published February 1, 2016. Updated 2022. Accessed August 5, 2025. https://www.usp.org/compounding/gener- al-chapter-hazardous-drugs-handling-healthcare", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 30 .Boiano JM,2015.pdf: Respondents were asked if they performed specific activities while wearing gloves that had been used to administer antineoplastic drugs. The most common activity reported by 6 of every 10 respondents was \u201ctouch I.V. pump or bed controls.\u201d Other reported activities included: \u201ctouch waste basket,\u201d \u201cuse pens/pencils,\u201d \u201ctouch door knobs, cabinets, or drawers,\u201d \u201cuse computer or calculator,\" \"handle files or charts,\u201d among others (Table VI).", "validation_result": "Supported", "page_location": "Page 27, Glove Use: Activities Where Cross-Contamination May Occur (Done While Wearing Gloves That Were Used While Administering Antineoplastic Drugs)", "confidence_score": 0.94, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Hazardous Drug (HD) Contamination Check. 61% through IV pump/ bed controls", "reference_no": "30", "reference": "Boiano JM, Steege AL, Sweeney MH. Adherence to safe handling guidelines by health care workers who administer antineoplastic drugs. J Occup Environ Hyg. 2014;11(11):728-740. 31.United States Pharmaco- peial Convention. USP General Chapter <800> Hazardous Drugs\u2014Handling in Healthcare Settings. Published February 1, 2016. Updated 2022. Accessed August 5, 2025. https://www.usp.org/compounding/gener- al-chapter-hazardous-drugs-handling-healthcare", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 30 .Boiano JM,2015.pdf: Activities where cross-contamination may occur (i.e., activities done while wearing gloves that had been used to administer antineoplastic drugs)B|Touch I.V. pump or bed controls (1969) 61", "validation_result": "Supported", "page_location": "Page 21, Table VI", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Hazardous Drug (HD) Contamination Check. 26% through pens/ pencils", "reference_no": "30", "reference": "Boiano JM, Steege AL, Sweeney MH. Adherence to safe handling guidelines by health care workers who administer antineoplastic drugs. J Occup Environ Hyg. 2014;11(11):728-740. 31.United States Pharmaco- peial Convention. USP General Chapter <800> Hazardous Drugs\u2014Handling in Healthcare Settings. Published February 1, 2016. Updated 2022. Accessed August 5, 2025. https://www.usp.org/compounding/gener- al-chapter-hazardous-drugs-handling-healthcare", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 30 .Boiano JM,2015.pdf: Activities where cross-contamination may occur\n(i.e., activities done while wearing gloves that had\nbeen used to administer antineoplastic drugs)B\nTouch I.V. pump or bed controls (1969)\nTouch waste basket/garbage bags (1970)\nUse pens/pencils (1970)", "validation_result": "Supported", "page_location": "Page 21, Table VI", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Hazardous Drug (HD) Contamination Check. 20% through IV doorknobs/ cabinets", "reference_no": "30", "reference": "Boiano JM, Steege AL, Sweeney MH. Adherence to safe handling guidelines by health care workers who administer antineoplastic drugs. J Occup Environ Hyg. 2014;11(11):728-740. 31.United States Pharmaco- peial Convention. USP General Chapter <800> Hazardous Drugs\u2014Handling in Healthcare Settings. Published February 1, 2016. Updated 2022. Accessed August 5, 2025. https://www.usp.org/compounding/gener- al-chapter-hazardous-drugs-handling-healthcare", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 30 .Boiano JM,2015.pdf: Touch door knobs, cabinets, or drawers (1969) 20", "validation_result": "Supported", "page_location": "Page 21, Table VI", "confidence_score": 1.0, "matching_method": "Aggregated (Supported)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}, {"statement": "Hazardous Drug (HD) Contamination Check. USP <800> recommends sampling surfaces routinely", "reference_no": "31", "reference": "", "matched_paper": "Multiple PDFs (1/1 support)", "matched_evidence": "- 31.USP chapter 800.pdf: I am sorry, but I cannot find any information about routine surface sampling for hazardous drugs in the provided document.", "validation_result": "Not Found", "page_location": "N/A", "confidence_score": 1.0, "matching_method": "Aggregated (Not Found)", "analysis_summary": "Consolidated results from 1 sources", "confidence_band": "HIGH"}], "created_at": "2026-02-03T14:48:27.304473"}